Insulin for All Act of 2023
Source: Congress.gov ·
270 words in original text
What This Bill Does
This bill limits how much insulin manufacturers can charge for insulin sold in the United States. The bill sets a maximum price that manufacturers are allowed to charge for insulin.
Who It Affects
Insulin manufacturers selling insulin in the United States.
Key Provisions
• Insulin manufacturers cannot charge more than $20 per 1,000 units of insulin sold in the United States (Sec. 2(a))
• The insulin can be delivered in vials, pens, cartridges or other forms (Sec. 2(a))
• This price limit applies to insulin licensed under federal law and still being sold (Sec. 2(b))
What Changes
Manufacturers would be prohibited from charging prices higher than $20 per 1,000 units of insulin. Any price above this amount would violate this law.
Important Definitions
Insulin is defined as insulin that is licensed under federal Public Health Service Act requirements and continues to be marketed under that license.
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.